EP1856095 - QUINAZOLINE DERIVATIVES AS TYROSINE KINASE INHIBITORS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 29.06.2012 Database last updated on 31.08.2024 | Most recent event Tooltip | 18.07.2014 | Lapse of the patent in a contracting state New state(s): HU | published on 20.08.2014 [2014/34] | Applicant(s) | For all designated states AstraZeneca AB 151 85 Södertälje / SE | [2007/47] | Inventor(s) | 01 /
HALSALL, Christopher Thomas AstraZeneca R&D Alderley, Alderley Park Macclesfield, Cheshire SK10 4TG / GB | 02 /
HENNEQUIN, Laurent Francois Andre AstraZeneca, Z.I. La Pompelle Bp 1050 F-51689, Reims, Cedex 2 / FR | 03 /
PLOWRIGHT, Alleyn Thomas AstraZeneca R&D Alderley, Alderley Park Macclesfield, Cheshire SK10 4TG / GB | 04 /
STOREY, Richard AstraZeneca, Charter Way Macclesfield, Cheshire SK10 2NA / GB | 05 /
LENNON, Kieran AstraZeneca, Charter Way Macclesfield, Cheshire SK10 2NA / GB | [2007/47] | Representative(s) | Nelson, Michael Andrew, et al AstraZeneca AB Global Intellectual Property 151 85 Sodertalje / SE | [N/P] |
Former [2007/47] | Nelson, Michael Andrew, et al AstraZeneca AB, Global Intellectual Property 151 85 Sodertalje / SE | Application number, filing date | 06709888.9 | 24.02.2006 | [2007/47] | WO2006GB00656 | Priority number, date | GB20050004018 | 26.02.2005 Original published format: GB 0504018 | GB20050006657 | 31.03.2005 Original published format: GB 0506657 | GB20050024001 | 25.11.2005 Original published format: GB 0524001 | [2007/47] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2006090163 | Date: | 31.08.2006 | Language: | EN | [2006/35] | Type: | A1 Application with search report | No.: | EP1856095 | Date: | 21.11.2007 | Language: | EN | The application published by WIPO in one of the EPO official languages on 31.08.2006 takes the place of the publication of the European patent application. | [2007/47] | Type: | B1 Patent specification | No.: | EP1856095 | Date: | 24.08.2011 | Language: | EN | [2011/34] | Search report(s) | International search report - published on: | EP | 31.08.2006 | Classification | IPC: | C07D401/12, A61K31/517, A61P35/00 | [2007/47] | CPC: |
C07D401/12 (EP,KR,US);
A61K31/517 (KR);
A61P35/00 (EP);
A61P43/00 (EP)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2007/47] | Extension states | AL | 26.09.2007 | BA | 26.09.2007 | HR | 26.09.2007 | MK | 26.09.2007 | YU | 26.09.2007 | Title | German: | CHINAZOLINDERIVATE ALS TYROSINKINASEINHIBITOREN | [2007/47] | English: | QUINAZOLINE DERIVATIVES AS TYROSINE KINASE INHIBITORS | [2007/47] | French: | DÉRIVÉS DE QUINAZOLINE SERVANT D'INHIBITEURS DE TYROSINE KINASE | [2007/47] | Entry into regional phase | 26.09.2007 | National basic fee paid | 26.09.2007 | Designation fee(s) paid | 26.09.2007 | Examination fee paid | Examination procedure | 05.12.2006 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 26.09.2007 | Examination requested [2007/47] | 07.04.2009 | Despatch of a communication from the examining division (Time limit: M06) | 07.10.2009 | Reply to a communication from the examining division | 21.03.2011 | Communication of intention to grant the patent | 14.07.2011 | Fee for grant paid | 14.07.2011 | Fee for publishing/printing paid | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 07.04.2009 | Opposition(s) | 25.05.2012 | No opposition filed within time limit [2012/31] | Fees paid | Renewal fee | 29.02.2008 | Renewal fee patent year 03 | 28.03.2008 | Renewal fee patent year 04 | 01.03.2010 | Renewal fee patent year 05 | 28.02.2011 | Renewal fee patent year 06 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 24.02.2006 | AT | 24.08.2011 | BE | 24.08.2011 | CY | 24.08.2011 | CZ | 24.08.2011 | DK | 24.08.2011 | EE | 24.08.2011 | FI | 24.08.2011 | LT | 24.08.2011 | LV | 24.08.2011 | PL | 24.08.2011 | RO | 24.08.2011 | SI | 24.08.2011 | SK | 24.08.2011 | BG | 24.11.2011 | GR | 25.11.2011 | IS | 24.12.2011 | PT | 26.12.2011 | IE | 24.02.2012 | LU | 24.02.2012 | MC | 29.02.2012 | [2014/34] |
Former [2014/27] | AT | 24.08.2011 | |
BE | 24.08.2011 | ||
CY | 24.08.2011 | ||
CZ | 24.08.2011 | ||
DK | 24.08.2011 | ||
EE | 24.08.2011 | ||
FI | 24.08.2011 | ||
LT | 24.08.2011 | ||
LV | 24.08.2011 | ||
PL | 24.08.2011 | ||
RO | 24.08.2011 | ||
SI | 24.08.2011 | ||
SK | 24.08.2011 | ||
BG | 24.11.2011 | ||
GR | 25.11.2011 | ||
IS | 24.12.2011 | ||
PT | 26.12.2011 | ||
IE | 24.02.2012 | ||
LU | 24.02.2012 | ||
MC | 29.02.2012 | ||
Former [2013/29] | AT | 24.08.2011 | |
BE | 24.08.2011 | ||
CY | 24.08.2011 | ||
CZ | 24.08.2011 | ||
DK | 24.08.2011 | ||
EE | 24.08.2011 | ||
FI | 24.08.2011 | ||
LT | 24.08.2011 | ||
LV | 24.08.2011 | ||
PL | 24.08.2011 | ||
RO | 24.08.2011 | ||
SI | 24.08.2011 | ||
SK | 24.08.2011 | ||
BG | 24.11.2011 | ||
GR | 25.11.2011 | ||
IS | 24.12.2011 | ||
PT | 26.12.2011 | ||
IE | 24.02.2012 | ||
MC | 29.02.2012 | ||
Former [2013/08] | AT | 24.08.2011 | |
BE | 24.08.2011 | ||
CY | 24.08.2011 | ||
CZ | 24.08.2011 | ||
DK | 24.08.2011 | ||
EE | 24.08.2011 | ||
FI | 24.08.2011 | ||
LT | 24.08.2011 | ||
LV | 24.08.2011 | ||
PL | 24.08.2011 | ||
RO | 24.08.2011 | ||
SI | 24.08.2011 | ||
SK | 24.08.2011 | ||
GR | 25.11.2011 | ||
IS | 24.12.2011 | ||
PT | 26.12.2011 | ||
IE | 24.02.2012 | ||
MC | 29.02.2012 | ||
Former [2012/42] | AT | 24.08.2011 | |
BE | 24.08.2011 | ||
CY | 24.08.2011 | ||
CZ | 24.08.2011 | ||
DK | 24.08.2011 | ||
EE | 24.08.2011 | ||
FI | 24.08.2011 | ||
LT | 24.08.2011 | ||
LV | 24.08.2011 | ||
PL | 24.08.2011 | ||
RO | 24.08.2011 | ||
SI | 24.08.2011 | ||
SK | 24.08.2011 | ||
GR | 25.11.2011 | ||
IS | 24.12.2011 | ||
PT | 26.12.2011 | ||
MC | 29.02.2012 | ||
Former [2012/33] | AT | 24.08.2011 | |
BE | 24.08.2011 | ||
CY | 24.08.2011 | ||
CZ | 24.08.2011 | ||
DK | 24.08.2011 | ||
EE | 24.08.2011 | ||
FI | 24.08.2011 | ||
LT | 24.08.2011 | ||
LV | 24.08.2011 | ||
PL | 24.08.2011 | ||
RO | 24.08.2011 | ||
SI | 24.08.2011 | ||
SK | 24.08.2011 | ||
GR | 25.11.2011 | ||
IS | 24.12.2011 | ||
PT | 26.12.2011 | ||
Former [2012/23] | AT | 24.08.2011 | |
BE | 24.08.2011 | ||
CY | 24.08.2011 | ||
CZ | 24.08.2011 | ||
EE | 24.08.2011 | ||
FI | 24.08.2011 | ||
LT | 24.08.2011 | ||
LV | 24.08.2011 | ||
PL | 24.08.2011 | ||
RO | 24.08.2011 | ||
SI | 24.08.2011 | ||
SK | 24.08.2011 | ||
GR | 25.11.2011 | ||
IS | 24.12.2011 | ||
PT | 26.12.2011 | ||
Former [2012/21] | AT | 24.08.2011 | |
BE | 24.08.2011 | ||
CY | 24.08.2011 | ||
CZ | 24.08.2011 | ||
FI | 24.08.2011 | ||
LT | 24.08.2011 | ||
LV | 24.08.2011 | ||
PL | 24.08.2011 | ||
SI | 24.08.2011 | ||
GR | 25.11.2011 | ||
IS | 24.12.2011 | ||
PT | 26.12.2011 | ||
Former [2012/17] | AT | 24.08.2011 | |
BE | 24.08.2011 | ||
CY | 24.08.2011 | ||
FI | 24.08.2011 | ||
LT | 24.08.2011 | ||
LV | 24.08.2011 | ||
PL | 24.08.2011 | ||
SI | 24.08.2011 | ||
GR | 25.11.2011 | ||
IS | 24.12.2011 | ||
PT | 26.12.2011 | ||
Former [2012/12] | AT | 24.08.2011 | |
CY | 24.08.2011 | ||
FI | 24.08.2011 | ||
LT | 24.08.2011 | ||
LV | 24.08.2011 | ||
PL | 24.08.2011 | ||
SI | 24.08.2011 | ||
GR | 25.11.2011 | ||
IS | 24.12.2011 | ||
PT | 26.12.2011 | ||
Former [2012/11] | AT | 24.08.2011 | |
FI | 24.08.2011 | ||
LT | 24.08.2011 | ||
LV | 24.08.2011 | ||
PL | 24.08.2011 | ||
SI | 24.08.2011 | ||
GR | 25.11.2011 | ||
IS | 24.12.2011 | ||
PT | 26.12.2011 | ||
Former [2012/10] | FI | 24.08.2011 | |
LT | 24.08.2011 | ||
GR | 25.11.2011 | ||
IS | 24.12.2011 | ||
PT | 26.12.2011 | ||
Former [2012/09] | FI | 24.08.2011 | |
LT | 24.08.2011 | ||
IS | 24.12.2011 | ||
PT | 26.12.2011 | ||
Former [2012/08] | LT | 24.08.2011 | |
IS | 24.12.2011 | Cited in | International search | [DX]WO03082831 (ASTRAZENECA AB [SE], et al) [DX] 1-24 * page 4, line 32 - page 5, line 6 * * examples 2,4,24,25,46 * * claim 1 *; | [DA]WO03082290 (BOEHRINGER INGELHEIM PHARMA [DE], et al) [DA] 1-24 * page 1, lines 5-16 * * claim 1 *; | [A]WO2005012290 (ASTRAZENECA AB [SE], et al) [A] 1-24* claim 1 * |